3B Blackbio Dx Limited Share Price & Analysis
₹1460.10−1.76%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹1460.10−1.76%Open
₹1513.90High
₹1513.90Low
₹1411.20Close
₹1460.1052W High
₹1750.0052W Low
₹1084.00Volume
20KLot Size
1Sector
HealthcareMarket Cap
₹1K CrFace Value
₹10Small Cap
Price Chart
Candle
Range
Fundamentals
P/E
22.60Sector P/E
54.70P/B
3.34EPS
₹66.92ROE
19.80%ROCE
25.50%D/E Ratio
0.01Div Yield
0.27%Book Value
₹378.00Strengths
- Strong return on equity (ROE 19.8%)
- Efficient capital deployment (ROCE 25.5%)
- Attractively valued vs sector (P/E 22.6x vs industry 54.7x)
- Virtually debt-free
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
3BBLACKBIO · as of Mar 2026
Promoters41.28%
FII2.49%0.19pp
DII1.60%0.14pp
Public54.64%0.35pp
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 38.43% | 41.29% | 41.28% | 41.28% | 41.28% | 41.28% |
| FII | 3.38% | 2.97% | 3.28% | 3.27% | 2.68% | 2.49% |
| DII | 1.18% | 1.89% | 1.96% | 1.96% | 1.74% | 1.60% |
| Public | 56.99% | 53.85% | 53.48% | 53.48% | 54.29% | 54.64% |
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹50.35 Cr 48.5% | ₹33.9 Cr 52.5% | ₹22.23 Cr 1.2% | ₹22.5 Cr 11.4% | ₹25.39 Cr 12.9% | ₹29.15 Cr 50.0% | ₹19.43 Cr 15.5% | ₹23 Cr |
| Op. Profit | ₹21.72 Cr 47.5% | ₹14.73 Cr 24.5% | ₹11.83 Cr 49.4% | ₹7.92 Cr 47.4% | ₹15.07 Cr 6.8% | ₹16.17 Cr 47.7% | ₹10.95 Cr 9.5% | ₹10 Cr |
| OPM | 43.1% 0.7% | 43.5% 18.4% | 53.2% 51.2% | 35.2% 40.7% | 59.4% 7.0% | 55.5% 1.6% | 56.4% 31.1% | 43.0% |
| Net Profit | ₹22.44 Cr 49.2% | ₹15.04 Cr 18.9% | ₹12.65 Cr 57.3% | ₹8.04 Cr 40.4% | ₹13.49 Cr 9.3% | ₹14.87 Cr 31.6% | ₹11.3 Cr 25.6% | ₹9 Cr |
| EPS (₹) | 25.32 47.7% | 17.14 16.8% | 14.67 49.8% | 9.79 37.3% | 15.61 8.6% | 17.07 31.6% | 12.97 25.6% | 10.33 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹142 Cr 47.9% | ₹96 Cr 29.7% | ₹74 Cr 19.4% | ₹62 Cr 23.5% | ₹81 Cr 64.3% | ₹227 Cr 682.8% | ₹29 Cr 26.1% | ₹23 Cr 0.0% | ₹23 Cr 43.8% | ₹16 Cr |
| Expenses | ₹85 Cr 84.8% | ₹46 Cr 12.2% | ₹41 Cr 24.2% | ₹33 Cr 25.0% | ₹44 Cr 42.9% | ₹77 Cr 285.0% | ₹20 Cr 25.0% | ₹16 Cr 11.1% | ₹18 Cr 28.6% | ₹14 Cr |
| Op. Profit | ₹57 Cr 14.0% | ₹50 Cr 51.5% | ₹33 Cr 13.8% | ₹29 Cr 21.6% | ₹37 Cr 75.3% | ₹150 Cr 1566.7% | ₹9 Cr 28.6% | ₹7 Cr 40.0% | ₹5 Cr 66.7% | ₹3 Cr |
| OPM | 40.0% 23.1% | 52.0% 18.2% | 44.0% 6.4% | 47.0% 2.2% | 46.0% 30.3% | 66.0% 106.3% | 32.0% 3.2% | 31.0% 34.8% | 23.0% 43.8% | 16.0% |
| Other Income | ₹26 Cr 73.3% | ₹15 Cr 15.4% | ₹13 Cr 85.7% | ₹7 Cr 0.0% | ₹7 Cr 133.3% | ₹3 Cr 50.0% | ₹2 Cr 100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr 100.0% | ₹1 Cr 0.0% | ₹1 Cr |
| Depreciation | ₹5 Cr 400.0% | ₹1 Cr 0.0% | ₹1 Cr 0.0% | ₹1 Cr 0.0% | ₹1 Cr 0.0% | ₹1 Cr 0.0% | ₹1 Cr 0.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| PBT | ₹77 Cr 20.3% | ₹64 Cr 45.5% | ₹44 Cr 25.7% | ₹35 Cr 18.6% | ₹43 Cr 71.7% | ₹152 Cr 1420.0% | ₹10 Cr 42.9% | ₹7 Cr 40.0% | ₹5 Cr 400.0% | ₹1 Cr |
| Tax % | 22.0% 12.0% | 25.0% 10.7% | 28.0% 3.7% | 27.0% 3.8% | 26.0% 4.0% | 25.0% 8.7% | 23.0% 8.0% | 25.0% 4.2% | 24.0% 26.3% | 19.0% |
| Net Profit | ₹60 Cr 25.0% | ₹48 Cr 50.0% | ₹32 Cr 23.1% | ₹26 Cr 18.8% | ₹32 Cr 71.9% | ₹114 Cr 1325.0% | ₹8 Cr 60.0% | ₹5 Cr 66.7% | ₹3 Cr 200.0% | ₹1 Cr |
| EPS (₹) | 68.27 22.9% | 55.57 48.6% | 37.4 8.2% | 34.55 19.4% | 42.89 71.7% | 151.66 1381.1% | 10.24 25.2% | 8.18 52.9% | 5.35 204.0% | 1.76 |
| Div Payout | 7.0% 0.0% | 7.0% 12.5% | 8.0% 0.0% | 8.0% 66.7% | 24.0% 300.0% | 6.0% 14.3% | 7.0% 16.7% | 6.0% 33.3% | 9.0% 47.1% | 17.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||||
| Equity Capital | ₹9 Cr 0.0% | ₹9 Cr 0.0% | ₹9 Cr 0.0% | ₹9 Cr 28.6% | ₹7 Cr 0.0% | ₹7 Cr 0.0% | ₹7 Cr 16.7% | ₹6 Cr 0.0% | ₹6 Cr 0.0% | ₹6 Cr |
| Reserves | ₹290 Cr 11.5% | ₹260 Cr 21.5% | ₹214 Cr 15.7% | ₹185 Cr 26.7% | ₹146 Cr 16.8% | ₹125 Cr 400.0% | ₹25 Cr 56.3% | ₹16 Cr 33.3% | ₹12 Cr 140.0% | ₹5 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr 100.0% | ₹1 Cr 50.0% | ₹2 Cr 33.3% | ₹3 Cr 50.0% | ₹2 Cr 50.0% | ₹4 Cr 33.3% | ₹6 Cr 0.0% | ₹6 Cr 33.3% | ₹9 Cr |
| Other Liabilities | ₹42 Cr 55.6% | ₹27 Cr 12.5% | ₹24 Cr 26.3% | ₹19 Cr 48.6% | ₹37 Cr 37.3% | ₹59 Cr 555.6% | ₹9 Cr 12.5% | ₹8 Cr 33.3% | ₹6 Cr 0.0% | ₹6 Cr |
| Total Liabilities | ₹341 Cr 15.2% | ₹296 Cr 19.4% | ₹248 Cr 15.9% | ₹214 Cr 11.5% | ₹192 Cr 1.0% | ₹194 Cr 331.1% | ₹45 Cr 25.0% | ₹36 Cr 20.0% | ₹30 Cr 15.4% | ₹26 Cr |
Assets | ||||||||||
| Fixed Assets | ₹17 Cr 142.9% | ₹7 Cr 0.0% | ₹7 Cr 12.5% | ₹8 Cr 14.3% | ₹7 Cr 40.0% | ₹5 Cr 25.0% | ₹4 Cr 0.0% | ₹4 Cr 0.0% | ₹4 Cr 33.3% | ₹3 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹160 Cr 2.6% | ₹156 Cr 33.3% | ₹117 Cr 27.2% | ₹92 Cr 1.1% | ₹93 Cr 57.6% | ₹59 Cr 5800.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹163 Cr 23.5% | ₹132 Cr 7.3% | ₹123 Cr 7.9% | ₹114 Cr 22.6% | ₹93 Cr 28.5% | ₹130 Cr 225.0% | ₹40 Cr 25.0% | ₹32 Cr 23.1% | ₹26 Cr 18.2% | ₹22 Cr |
| Total Assets | ₹341 Cr 15.2% | ₹296 Cr 19.4% | ₹248 Cr 15.9% | ₹214 Cr 11.5% | ₹192 Cr 1.0% | ₹194 Cr 331.1% | ₹45 Cr 25.0% | ₹36 Cr 20.0% | ₹30 Cr 15.4% | ₹26 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹43 Cr 59.3% | ₹27 Cr 35.0% | ₹20 Cr 45.9% | ₹37 Cr 62.2% | ₹98 Cr 1300.0% | ₹7 Cr 75.0% | ₹4 Cr 100.0% | ₹2 Cr 100.0% | ₹1 Cr 0.0% | ₹1 Cr |
| Investing CF | ₹-33 Cr 65.0% | ₹-20 Cr 233.3% | ₹15 Cr 153.6% | ₹-28 Cr 60.0% | ₹-70 Cr 6900.0% | ₹-1 Cr 0.0% | ₹-1 Cr 0.0% | ₹-1 Cr | ₹0 Cr | ₹0 Cr |
| Financing CF | ₹-3 Cr 25.0% | ₹-4 Cr 20.0% | ₹-5 Cr 66.7% | ₹-15 Cr 650.0% | ₹-2 Cr 300.0% | ₹1 Cr 200.0% | ₹-1 Cr | ₹0 Cr | ₹0 Cr 100.0% | ₹-1 Cr |
| Net Cash Flow | ₹7 Cr 133.3% | ₹3 Cr 90.0% | ₹30 Cr 600.0% | ₹-6 Cr 123.1% | ₹26 Cr 271.4% | ₹7 Cr 250.0% | ₹2 Cr 100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹42 Cr 61.5% | ₹26 Cr 44.4% | ₹18 Cr 48.6% | ₹35 Cr 63.5% | ₹96 Cr 1500.0% | ₹6 Cr 100.0% | ₹3 Cr 200.0% | ₹1 Cr | ₹0 Cr 100.0% | ₹1 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 138d 22.9% | 179d 10.5% | 200d 47.1% | 136d 142.9% | 56d 77.8% | 252d 13.1% | 290d 12.0% | 259d 19.3% | 321d 13.4% | 283d |
| Inventory Days | 124d 12.1% | 141d 14.0% | 164d | — | — | — | — | — | 175d 22.4% | 143d |
| Days Payable | 28d 57.6% | 66d 4.3% | 69d | — | — | — | — | — | 186d 8.4% | 203d |
| Cash Conv. Cycle | 235d 7.1% | 253d 14.5% | 296d 117.6% | 136d 142.9% | 56d 77.8% | 252d 13.1% | 290d 12.0% | 259d 16.5% | 310d 39.0% | 223d |
| Working Capital Days | 169d 21.4% | 215d 10.8% | 241d 48.8% | 162d 149.2% | 65d 76.4% | 275d 4.2% | 287d 13.4% | 253d 2.4% | 247d 20.5% | 205d |
| ROCE | 26.0% 23.8% | 21.0% 10.5% | 19.0% 29.6% | 27.0% 83.3% | 162.0% 422.6% | 31.0% 10.7% | 28.0% 16.7% | 24.0% 84.6% | 13.0% 85.7% | 7.0% |
Source: Screener.in · Lower days = better efficiency
About 3B Blackbio Dx Limited
Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products[1]
HealthcareHealthcare Services
Related Analysis
Frequently Asked Questions
What is 3B Blackbio Dx Limited share price today?
3B Blackbio Dx Limited (3BBLACKBIO) is currently trading at ₹1,460.1 on NSE, down 1.76% as of the last market session. Prices update daily after market close on MarketNetra.
Is 3B Blackbio Dx Limited available in F&O (Futures & Options)?
Yes, 3B Blackbio Dx Limited (3BBLACKBIO) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is 3B Blackbio Dx Limited 52-week high and low?
3B Blackbio Dx Limited's 52-week high is ₹1,750 and the 52-week low is ₹1,084. The current price of ₹1,460.1 is 16.6% below the 52W high.
What is 3B Blackbio Dx Limited P/E ratio?
3B Blackbio Dx Limited's current P/E ratio is 22.6. This indicates the market is paying ₹22.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade 3B Blackbio Dx Limited options?
3B Blackbio Dx Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade 3BBLACKBIO options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.